Please find link below for webcast on the press conference on D:A:D study results presented at CROI 2017.
Webcast of press conference
Please find link for both D:AD presentations at CROI 2017 below:
Association between Cardiovascular Disease & Contemporarily Used Protease Inhibitors. presented by Lene Ryom on behalf of the D:A:D. study
Cessation of cigarette smoking and the impact on cancer incidence in the D:A:D Study. presented by Leah Shepherd on behalf of the D:A:D study
PRESENTATION . WEBCAST
The press review is based on this EuroSIDA publication from 2016:
Infection-related and -unrelated malignancies, HIV and the aging population. abstract
Conference on Retroviruses and Opportunistic Infections 13-16 February 2017
CHIP was represented with 7 presentations, 2 oral presentations, 1 themed discussion and 4 posters
Please find all presentations here
HIV in Europe presents the 2nd HepHIV conference:
HepHIV 2017 Conference: HIV and Viral Hepatitis: Challenges of Timely Testing and Care
CHIP was represented with 10 presentations! 4 oral presentations and 6 poster presentations. Please find them all HERE
New publication from the TB:HIV study compares one-year mortality of HIV-TB patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe and Latin America. Read it HERE
Please find vaccine recommendations from MATCH here
CHIP will be represented at Glasgow 2016 with 8 presentations! 4 oral presentations, 2 poster presentations and two thistle poster presentations.
Please find them HERE
EuroSIDA study finds shift in cancers as HIV-positive people age.
Please find the presentations from TB2016 and AIDS2016 HERE
Registration for the upcoming TB2016 conference preceding IAS in Durban in July is now open.
Abstract submission deadline is 1 April 2016.
We hope to see many of you there!
Please find the 8 CHIP presentations from CROI 2016 HERE.
Read the latest TB:HIV publication accepted in The Lancet HIV
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.
D Podlekareva, AM Efsen et al.
CHIP will be represented at CROI 2016 with 8 presentations!
EuroSIDA (3 presentations)
D:A:D (3 presentations)
START (1 presentation)
NEAT001 (1 presentation)
Read the latest PERSIMUNE publication
Sustainable HIV treatment in Africa through viral-load-informed differentiated care.
A Phillips et al.
CHIP will be represented at EACS 2015 with 19 presentations!
EuroSIDA (3 oral, 6 posters)
TB:HIV (1 oral)
COHERE (1 oral)
HIDES 2 (1 poster)
OptTEST (5 posters)
INSIGHT (1 poster)
D:A:D (1 poster)
CHIP was represented at IAS 2015 with the following presentation: "Excess TB mortality in HIV patients in Eastern Europe: restructured approach to care needed". Find it HERE.
Latest News Link
DR TV Avisen (Danish Broadcast)
(e) Science News
Read all press coverage of the START Study results here
Read the article on the groundbreaking results of the START study on the benefits of early antiretroviral treatment. Now available online
The START study: Design, conduct and main results
Presented by Jens Lundgren, Rigshospitalet, University of Copenhagen, Denmark
Monday 20th July 11-12.30 Ballroom A, Session title: The Strategic Timing of Antiretroviral Treatment (START) Study: Results and their Implications.
Excess TB mortality in HIV patients in Eastern Europe: restructured approach to care needed. Presented by Anna Schultze on behalf of the TB:HIV study group in EuroCoord.
Monday 20th July 11:30-11:45 Ballroom C-D. Session Title: HIV and TB: Gaps and Opportunities. Abstract number MOAB0203.
Community-based HIV rapid testing and linkage to care. Efficacy of multi-country testing initiatives during European testing week 2014
Presented by Anna Zakowicz
Wednesday 22nd July 12.30-14, Exhibition located in Hall B on West Exhibition Level, Poster number: WEPEC672
START, one of the largest ongoing HIV studies, has announced early results regarding the long-debated question of when to start HIV-infected individuals on treatment.
Read the press release from the NIH here.
Have questions about the study results and what they mean for HIV patients? Find answers on the NIH Q & A page.
Go to CHIP's START news page or click on the links below to read what other news sources around the world are saying about the groundbreaking results of the START study:
The New York Times
"The indications for Transplantation (TX) : a risk factor for ALT-flares and death during post-transplant follow up (FU)" . Presented by Louise Lundgren. Authors: Louise Lundgren*, Caspar Da Cunha-Bang, Amanda Mocroft, Lars Vindeløv, Finn Gustafsson, Martin Iversen, Nikolai Kirkby, Jens Dilling Lundgren, Allan Rasmussen, Søren Schwartz Sørensen, Henrik Sengeløv – on behalf of the MATCH study group.
Saturday 25th April 15.30-16.30CET, Poster number: P0266, Poster session: Infections in Organ Transplant Recipients (P14)
"High Proportion of Symptomatic CMV Infection Despite Optimal Practice of a Preemptive CMV Strategy for Recipients of Solid Organ Transplantation (SOT) and Hematopoietic Stem Cell Transplantation (HSCT)" Presented by Isabelle Lodding. Authors: I. Lodding, C. Da-Cunha Bang, H. Sengeløv, M. Iversen, A. Rasmussen, L. Vindeløv, F. Gustafsson, N. Kirkby, A. Mocroft, S. Schwartz Sørensen, J. Lundgren on the behalf of the MATCH programme study group.
Monday 27th of April 15:15CET. abstract
CHIP was represented at CROI 2015 with presentations from the EuroSIDA study, the D:A:D study and INSIGHT. Find them all HERE.
EuroSIDA will be represented at the annual Conference on Retroviruses and Opportunistic Infections (CROI) with the following presentations:
"A Prognostic Score Estimating the Risk of Liver-Related Death Among HIV/HCV Coinfected Subjects", presented by Amanda Mocroft, submitting author: Daniel Grint. Session P-N1, February 24th 2.30-4.00 PM. Abstract number 637.
"New Marker of Standard-of-ART Care: Percentage of Time on cART With Suppressed HIV-RNA", presented by Kamilla Laut. Session P-K2, February 24th 2.30-4.00PM. Abstract number 561.
DR News explains how PERSIMUNE and 60 million danish kroners will help determine why some people can't tolerate chemotherapy or organ transplantations article (in Danish)